27/02/2025by EOS Intelligence Pet and Animal Health M&A: What’s the Scoop on the Industry’s Latest Shake-ups?
30/09/2024by EOS Intelligence New Directions in Alzheimer’s Diagnostics: Will Blood Tests Replace CSF and PET?
26/09/2024by EOS Intelligence Phase 3 Drug Candidates – A Ray of Hope in Alzheimer’s Disease Bleak Treatment Landscape?
19/09/2024by EOS Intelligence Pharma Companies Navigate Their Way through Ac-225 amidst Supply Constraints
20/06/2024by EOS Intelligence IRA: Are Patients Winning at the Cost of the US Pharma Sectoral Growth?
30/05/2024by EOS Intelligence An Era of Innovation: Novel Drugs Redefining Multiple Sclerosis Treatment Paradigm